| (3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosane-1,2 |
| (3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S |
| (3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl |
| (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino] |
| (3S)-3-azanyl-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino |
| (Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide |
| [125I]CCK-8 |
| 1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein |
| 126S323 |
| 25126-32-3 |
| 25345-10-2 |
| 3-amino-4-[[1-[[1-[[2-[[1-[[1-[[1-[(1-amino-1-oxo-3-phenylpropan-2-yl)amino]-4-hydroxy-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsul |
| 89911-55-7 |
| 9038-72-6 |
| 91921-74-3 |
| A817659 |
| AC1L1OGF |
| AKOS015896031 |
| AKOS016340423 |
| AM021026 |
| Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Asp-Tyr[SO3 H]-Met-Gly-Trp-Met -Asp-Phe-NH2 |
| Asp-Tyr[SO3 H]-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| BDBM21147 |
| C49H62N10O16S3 |
| Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine- |
| CAS-25126-32-3 |
| CCK 26-33, sulfated |
| CCK C-terminal octapeptide |
| CCK Octapeptide, sulfated |
| CCK-8 |
| CCK-8 (sulphated) |
| CCK-8, sulfated |
| CCK-8(SO3) |
| CHEBI:135946 |
| CHEMBL1121 |
| cholecystokinin 8 |
| cholecystokinin C-terminal octapeptide |
| cholecystokinin fragment 26-33 amide (sulphated) |
| Cholecystokinin octapeptide |
| Cholecystokinin Octapeptide, sulfated |
| Cholecystokinin-8 |
| Cholecystokinin-pancreozymin |
| CS-042 |
| CS-5963 |
| D05845 |
| D09ZAX |
| D0I8AF |
| D0TL7L |
| DB09142 |
| DR003692 |
| DSSTox_CID_28543 |
| DSSTox_GSID_48617 |
| DSSTox_RID_82815 |
| DTXSID7048617 |
| EINECS 246-639-0 |
| FT-0630515 |
| GTPL864 |
| H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Human CCK-8 |
| HY-P0093 |
| I06-1840 |
| IZTQOLKUZKXIRV-YRVFCXMDSA-N |
| Kinevac (TN) |
| L-alpha-Aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide |
| L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide hydrogen sulfate (ester) |
| LS-53094 |
| M03GIQ7Z6P |
| MFCD00079849 |
| MolPort-006-124-517 |
| NCGC00167273-01 |
| NCGC00183278-01 |
| NCGC00183363-01 |
| O411 |
| Pancreozymin |
| Pancreozymin C-terminal octapeptide |
| SC-47569 |
| SCHEMBL122365 |
| SCHEMBL1425223 |
| Sincalida |
| Sincalida [INN-Spanish] |
| Sincalide |
| Sincalide (Kinevac) |
| Sincalide (USP/INN) |
| Sincalide [USAN:BAN:INN] |
| Sincalide [USAN:USP:INN:BAN] |
| Sincalidum |
| Sincalidum [INN-Latin] |
| SQ 19844 |
| SQ-19844 |
| Syncalide |
| Tox21_112955 |
| Tox21_113481 |
| UNII-M03GIQ7Z6P |
